//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Publishing the latest advances across all areas of cancer research and oncology. Part of @natureportfolio.nature.com 🌐 www.nature.com/natcancer/ 📍New York, London, Berlin and Heidelberg
Nature Cancer









Loading...
⭐️Online now Iron level and ferroptosis impair antitumor efficacy of CAR-T cells. by Dongrui Wang, Yongxian Hu, Pengxu Qian, He Huang & colleagues www.nature.com/articles/s43...
🍓☀️Check out our May Issue, now live! Including: ☑️Oncolytic virus and cytokine-based gene therapies ☑️Myeloid plasticity, part of our Series on Tumor Heterogeneity and Plasticity ☑️DeepFAN, a model for human-AI collaboration and more! www.nature.com/natcancer/vo...
⭐️Check out the Perspective on cellular neighborhoods in cancer by Lichun Ma, @kaitanlab.bsky.social & co 🔗 www.nature.com/articles/s43... Part of our Series on Tumor Heterogeneity and Plasticity: www.nature.com/collections/...
New Article out today! CD300ld, upregulated in pathologically activated neutrophils, mediates contact-dependent suppression of cytotoxic CD8+ T cells by binding to phosphatidylserine, inhibiting antitumor immune responses and revealing a targetable checkpoint pathway. www.nature.com/articles/s43...
🌟 Online now! Read the Review on myeloid cell plasticity in cancer therapy by Dmitry Gabrilovich & colleagues 🔗 www.nature.com/articles/s43... Check out the rest of our Series on Tumor Heterogeneity and Plasticity here: www.nature.com/collections/...
⭐Out today! Read the phase I clinical trial on neoantigen DNA vaccine for patients with glioblastoma www.nature.com/articles/s43...
📢Online now! @moritzgerstung.bsky.social, Felix Sahm & co developed an AI algorithm that leverages H&E slides to classify central nervous system tumors into methylation-based subtypes reducing turnaround time to 12 min in prospective evaluation. www.nature.com/articles/s43...
⭐️Now online In a large cohort of patients with ICB-treated glioblastoma, Catherine J. Wu & colleagues show that baseline mesenchymal transcriptional state predicts therapy response, and transition to non-mesenchymal state results in acquired resistance. www.nature.com/articles/s43...
1d
9d
1mo
27d
27d
1mo
1d
3d
Registration and abstract submissions are now open for Next Generation Cancer Therapeutics. This Nature Conference will bring together leading global researchers who are transforming the landscape of cancer therapies for discussions and networking. go.nature.com/4eHSlnc #STEMConference
Impressive new study by the Wu lab in @natcancer.nature.com investigating the tumor cell features associated with #immunotherapy response in #glioblastoma Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma | Nature Cancer www.nature.com/articles/s43...
Iron-mediated ferroptosis impairs CAR-T cell function and antitumor efficacy - Nature Cancer
Huang and colleagues report that elevated iron levels are associated with ferroptosis of chimeric antigen receptor (CAR)-T cells and inhibition of ferroptosis improves antitumor efficacy of CAR-T cell...
www.nature.com
Tan and colleagues discuss recent advances in spatial omics and computational models that inform the classification and clinical relevance of cellular neighborhoods in cancer.
www.nature.com
Cellular neighborhoods in cancer - Nature Cancer
Zhao and colleagues show that CD300ld, upregulated in pathologically activated neutrophils, mediates contact-dependent suppression of cytotoxic CD8+ T cells by binding to phosphatidylserine, inhibitin...
www.nature.com
CD300ld on pathologically activated neutrophils promotes tumor immune suppression by binding phosphatidylserine on CD8+ T cells - Nature Cancer
Gabrilovich and colleagues provide an overview of myeloid cell plasticity during differentiation, within the tumor microenvironment and in response to therapy, and discuss the challenges to therapeuti...
www.nature.com
Harnessing myeloid cell plasticity for cancer therapy - Nature Cancer
Johanns and colleagues report the results (including safety, efficacy and immunogenicity) of a phase 1 clinical trial of a DNA-based personalized therapeutic cancer vaccine administered following surg...
www.nature.com
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial - Nature Cancer
Jin et al. developed an artificial intelligence tool that leverages histology to predict methylation-based central nervous system tumor subtypes and validated it for tumor classification, demonstratin...
www.nature.com
29d
Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes - Nature Cancer
In a large cohort of participants with immune-checkpoint-blockade-treated glioblastoma, Ghannam et al. show that baseline mesenchymal transcriptional state predicts therapy response and transition to ...
www.nature.com
8d
Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma - Nature Cancer
Nature Cancer
Nature Cancer
Nature Cancer
Nature Cancer
Nature Cancer
Nature Cancer
Nature Cancer
Nature Cancer
In a large cohort of participants with immune-checkpoint-blockade-treated glioblastoma, Ghannam et al. show that baseline mesenchymal transcriptional state predicts therapy response and transition to ...
www.nature.com
Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma - Nature Cancer
Nature Portfolio
Roman Sankowski